Key result
Microalbuminuria occurs in ~30% of non-diabetic UA/NSTEMI patients and strongly correlates with multivessel CAD.
Why the study?
Is microalbuminuria associated with the severity of coronary artery disease in non-diabetic patients presenting with UA/NSTEMI?
Cross-Sectional (n=70)
No
Is microalbuminuria associated with the severity of coronary artery disease in non-diabetic patients presenting with UA/NSTEMI?
Microalbuminuria may serve as a useful surrogate marker for the severity of coronary artery disease in non-diabetic patients presenting with UA/NSTEMI.
Answers are grounded in this paper and cite their sources.
Microalbuminuria may flag multivessel disease in non-diabetic UA/NSTEMI; leaves open whether it adds prognostic value beyond existing markers.
BACKGROUND: Microalbuminuria (MAU) is defined as an urinary albumin excretion rate between 20-200 mg/l or 30-300 mg/day. It is a surrogate marker for endothelial dysfunction and is independently associated with atherosclerotis in diabetic and in non-diabetic patients. We assessed the prevalence of MAU in non-diabetic patients who presented with UA/NSTEMI and the relation of MAU to the severity of coronary artery disease in patients at a cardiac care center in Iraq. METHODS: Seventy non-diabetic patients referred to the Iraqi Center for Heart Disease, Baghdad, between November 1st 2010 and June 1st 2011 with the diagnosis of UA/NSTEMI were included in this study. Physical examination, ECG and echocardiography were performed on all patients. TIMI ("Thrombolysis in Myocardial Infarction") risk score was obtained. Urine samples were collected and sent for quantitative determination of MAU. All patients underwent diagnostic coronary angiography. Data are give as mean (quantitative and percent) ± SD. RESULTS: Fifty-three men (76%) and 17 (24%) women (mean age 56 ± 12 years) were investigated. Overall 37 (53%) individuals presented with arterial hypertension and 41 (59%) with a history of smoking. 58 patients (83%) had ischemic ECG changes (defined as ST segment depression more than 1 mm from baseline, and/or T wave inversion), 52 (74%) had echocardiographic findings indicative of ischemia (defined as segmental wall motion abnormalities). Twenty-one (30%) patients tested positive for MAU. There was a significant correlation of echocardiographic signs of ischemia and MAU, (n = 20 (38%), p < 0.01). There was a clear relationship between MAU and TIMI risk score. Additionally, MAU was more common in patients with multivessel coronary artery disease (CAD) (p < 0.001). There was no statistically significant correlation between MAU and mean age, sex, smoking, and blood pressure. CONCLUSION: In this analysis of patients with UA/NSTEMI we found a strong correlation of microalbuminuria with echocardiographic changes and findings in coronary angiography.
No takes yet. Share an insight, caveat, or question.
Al-Saffar et al. (2015) conducted a cross-sectional in Unstable angina / non ST-segment elevation myocardial infarction (UA/NSTEMI) (n=70). Microalbuminuria (MAU) assessment vs. MAU negative patients was evaluated on Correlation between microalbuminuria and severity of coronary artery disease (multivessel disease) (p=<0.001). Microalbuminuria was present in 30% of non-diabetic patients with UA/NSTEMI and strongly correlated with multivessel coronary artery disease and echocardiographic signs of ischemia.
Synapse has enriched 10 related papers. Consider them for comparative context: